Gene Query: WNT7B

Dataset Description Geneva Score
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 88.45
Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML 63.47
Pharmacologic inhibition of STAT5 in AML 61.48
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 57.87
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 57.87
METTL3 promotes translation in human cancer cells 55.59
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 52.52
Mitotic stress is an integral part of the oncogene-induced senescence program that promotes multinucleation and cell cycle arrest 43.52
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 42.98
Self-organization of polarized cerebellar plate neuroepithelium in three-dimensional culture of human pluripotent stem cells 42.33
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 41.47
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 38.34
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 38.03
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 36.2
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 35.34
RNA-seq analysis of AML cells in response to ASLAN003 33.75
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 32.31
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 31.75
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 31.69
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 31.69
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 31.35
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 31.35
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 31.22
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 30.8
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 30.8
Analysis of MGE Transcriptomes with or without Ctnnb1 knockout in human through RNA Sequencing 30.36
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 30.09
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 29.85
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 27.53
NHLRC1 re-expression in cancer cells 27.26
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 25.73
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 25.73
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 25.56
High-Throughput Kinetic Analysis of Fractional Killing 25.47
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 25.18
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 25.02
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 24.75
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 24.59
Effect of PRDM11 depletion in U2932 cells 24.1
Genome-wide transcriptome profiles in Control and Schizophrenia hiPSC-dervied NPC [RNA-seq] 23.97
Next-generation sequencing of control and schizophrenia hiPSC derived NPC 23.97
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 23.64
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 23.34
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 23.0
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling 22.75
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 22.66
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 22.55
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 22.48
Maturation of human iNSCs 22.33
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 21.84
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 21.59
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 21.56
Nutritional control of protein translation 21.41
TGF-β promotes genomic instability after loss of RUNX3 21.13
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 21.0
Altering cancer transcriptomes using epigenomic inhibitors 21.0
TCF7L1 knockdown in pancreatic cancer 20.26
Gene expression analysis of immortalized human liver progenitor-like cells in culture 19.66
MARS Seq data from human cortical organoids 19.19
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 19.1
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 19.02
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 18.99
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 18.98
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 18.93
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 18.84
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 18.52
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 18.35
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 18.35
Regulation of hypoxia-inducible factor activity by ZMYND8 18.01
Control of prostate tumour growth by the long non-coding RNA GHSROS 18.01
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 17.9
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 16.99
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 16.95
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 16.85
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 16.59
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 16.41
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 16.22
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 16.16
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 16.07
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 15.87
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 15.34
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 15.34
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 15.32
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 15.32
GATA3-mediated chromatin reprogramming in breast cancer cells 15.17
Inhibition of TNBC metastasis by Gpx1 15.06
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 14.95
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 14.93
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 14.79
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 14.79
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 14.57
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 14.54
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 14.43
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 14.42
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 14.23
Tracing Enhancer Networks using Epigenetic Traits (TENET) 14.21
Global modulation of signaling pathways by SARM RAD140 in AR/ER+ breast cancer xenografts 14.18
MOF acetyl transferase regulates transcription and respiration in mitochondria 13.96
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 13.92
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 13.86
Finding missing proteins from epigenetically manipulated human cells 13.78
Engineered human pluripotent stem cell-derived intestinal tissues with a functional enteric nervous system 13.67
Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras 13.66
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 13.65
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 13.55
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins 13.12
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 13.0
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 12.99
Disruption of GRIN2B impairs differentiation in human neurons 12.97
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 12.63
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 12.6
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 12.48
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 12.47
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 12.47
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 12.34
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 12.21
Neurofibroma 12.21
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 12.08
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 12.07
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 12.07
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 12.05
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 11.93
Genome wide expression change in LCC2 and MCF-7 cells 11.86
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 11.79
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 11.74
Effect of disulfiram treatment on pediatric high grade glioma 11.67
Microprocessor mediates transcription termination in long noncoding microRNA genes 11.62
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 11.62
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 11.62
STRIPAK directs PP2A activity to promote oncogenic transformation 11.61
Characterization of parental and rociletinib-resistant derived H1975 cell lines 11.52
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 11.47
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 11.41
Gene expression alterations of pancreatic intraepithlial neoplasia 11.34
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 11.24
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 11.18
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 11.14
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes 11.0
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes [RNA-Seq] 11.0
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 10.92
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 10.88
FOXP1 orchestration of ASD-relevant signaling pathways. 10.88
RNA-Seq analysis of neurons derived from induced pluripotent stem cells reprogrammed from dental pulp 10.86
H1609088 Human RNA-Sequencing 10.79
Electronic cigarettes 10.78
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 10.68
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 10.68
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 10.66
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 10.62
Global epigenomic reconfiguration during mammalian brain development 10.51
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 10.5
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 10.5
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 10.44
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 10.44
FOXD3 is a novel tumor suppressor in lung cancer 10.44
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 10.43
Total RNA sequencing of APC mutant and wt colonic organoids 10.41
RNAseq analysis of ESRP regulated splicing events in prostate cancer 10.37
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 10.36
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 10.33
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 10.3
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 10.24
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 10.12
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 10.12
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 10.09
CHD1 regulates cell fate determination by activation of differentiation-induced genes 9.85
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 9.78
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 9.72
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 9.65
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 9.65
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 9.58
Effect of Hotair overexpression in human breast cancer cell lines 9.52
RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 9.46
microRNA-seq and RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 9.46
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 9.45
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 9.45
Comparison of microRNA Profiling Platforms 9.45
Comparison of microRNA Profiling Platforms (HTS) 9.45
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 9.17
Role of FGFR1 in neuronal devlopment 9.09
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 9.04
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 9.04
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 8.98
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 8.98
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 8.96
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 8.86
Transcriptomic profile of human embryonic renal corpuscles 8.8
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 8.76
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 8.65
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 8.65
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 8.58
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 8.56
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 8.56
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 8.56
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived NPCs 8.55
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 8.55
Rorc disruption in human FG pancreatic cancer cells 8.44
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 8.4
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 8.36
Effect of drugs on transcriptomic profiles 8.27
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 8.23
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 8.12
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 8.07
IRF1 regulates IFN dependent and independent gene expression 8.03
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 8.01
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 7.99
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 7.94
RNAseq data from Mesenchymal stem cells treated with TCDD or 1-methyl tryptophan 7.92
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 7.85
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 7.83
RNA-seq data from human lymphoma cell lines 7.78
ChIP-seq and RNA-seq from human lymphoma cell lines 7.78
mRNAseq of Huntington's disease and control patient iPSC-derived brain microvascular endothelial cells 7.77
Transcriptional change of THP-1 after HSV-1UL37WT or HSV-1UL37C819S 7.73
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 7.71
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 7.65
RNA-seq analysis of RALD iPSCs after in vitro differentiation 7.62
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma [RNA-seq] 7.55
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma 7.55
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 7.54
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 7.54
Gene expression profile in breast cancer cell lines using RNA sequencing 7.45
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 7.35
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 7.31
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 7.31
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 7.13
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 7.12
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 7.02
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 7.0
Hydrogel scaffolds promote neural gene expression and structural reorganization in human astrocyte cultures 6.96
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 6.94
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 6.94
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 6.84
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 6.82
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 6.79
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 6.79
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 6.79
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 6.78
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 6.78
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 6.72
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 6.64
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 6.63
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 6.62
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 6.62
Capturing the Interactome of Newly Transcribed RNA 6.6
Capturing the Interactome of Newly Transcribed RNA (RICK) 6.6
RNA splicing alteration on glioblastoma and normal neural stem cells 6.59
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 6.57
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 6.54
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 6.54
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 6.52
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 6.5
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 6.46
Effect of CHKA knockdown on C4-2 cell transcriptome 6.45
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 6.45
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 6.41
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 6.38
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 6.33
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 6.32
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 6.29
RNA-seq analysis of breast cancer 6.27
RNA-seq analysis and shRNA screen of breast cancer 6.27
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 6.24
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 6.22
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 6.11
AR-independent prostate cancer is sustained through FGF signaling 6.1
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma 6.09
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) 6.09
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 6.08
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 6.08
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 6.06
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 5.94
CSL 5.94
CSL RNA-Seq on HKC and SCC cell lines 5.94
A549 cell transcriptome responses to infection with H7N9 influenza virus 5.92
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 5.91
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 5.89
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 5.89
Cajal bodies are linked to genome conformation [RNA-Seq] 5.88
Cajal bodies are linked to genome conformation 5.88
Ectoderm specification of H1 human embryonic stem cells 5.84
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 5.81
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 5.81
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 5.79
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 5.78
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 5.73
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 5.72
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 5.63
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 5.62
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 5.61
Targeting MTHFD2 in Acute Myeloid Leukemia 5.56
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 5.55
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 5.55
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 5.53
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 5.51
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 5.51
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 5.48
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 5.4
RNA editing in nascent RNA affects pre-mRNA splicing 5.38
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 5.29
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 5.27
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 5.27
Subtle asymmetry of gene expression in embryonic and foetal human brains 5.22
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 5.2
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 5.2
Regulation of poly(A) tail and translation during the somatic cell cycle 5.18
The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing [RNA-seq] 5.16
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 5.12
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 5.11
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 5.09
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 5.08
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 5.08
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 4.86
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 4.77
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 4.76
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 4.71
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 4.7
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 4.7
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 4.62
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 4.59
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 4.59
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 4.54
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 4.48
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 4.48
Disruption of the exocyst induces podocyte loss and dysfunction 4.42
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 4.38
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 4.37
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 4.35
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 4.35
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 4.35
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 4.35
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 4.34
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 4.34
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 4.23
RNA-seq of cancer cell lines treated with T-025 4.21
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 4.19
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 4.15
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 4.13
Total RNA sequencing of WT intestinal orgaonids. 4.1
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 4.1
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 4.1
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 4.07
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 4.05
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 4.05
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 4.01
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 4.0
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 3.9
Gene expression of thyroid cancer cell lines 3.85
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 3.84
RNA seq comparison between scrambled and shGRP78 cells 3.84
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 3.82
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 3.82
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 3.77
RNA-seq analyisis of PUM2 knockout cells 3.7
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 3.7
Androgen Receptor-regulated genes in prostate cancer cells 3.7
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 3.68
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 3.67
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 3.67
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 3.61
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 3.59
Gene expression analysis of breast cancer cell-lines 3.59
Gene expression and genome-wide location analysis of breast cancer cell-lines 3.59
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 3.58
PANCR, the PITX2 adjacent noncoding RNA, is specifically expressed in human left atria and regulates PITX2c expression 3.51
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 3.5
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 3.45
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 3.42
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 3.42
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 3.4
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 3.38
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 3.37
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 3.31
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 3.29
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 3.28
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 3.28
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 3.26
LIN28A modulates splicing and gene expression programs in breast cancer cells 3.26
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 3.17
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 3.15
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 3.13
RNA-seq in endometrial stromal tumors 3.13
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 3.1
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 3.09
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 3.08
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 2.97
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 2.93
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 2.91
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 2.87
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 2.87
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 2.82
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 2.82
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 2.8
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 2.79
RNA-seq in neurons derived from iPSCs in controls and patients with schizophrenia and 22q11 del 2.74
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 2.64
Expression profiles of the four human major ectodermal lineages 2.59
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 2.54
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 2.5
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 2.49
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 2.46
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 2.45
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 2.45
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 2.37
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 2.34
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 2.29
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 2.23
RNA seq_PDX2_SHP099 2.2
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 2.18
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 2.16
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 2.15
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 2.15
Dissecting neural differentiation regulatory networks through epigenetic footprinting 2.15
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 2.08
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 2.07
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 2.04
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 2.04
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 1.96
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 1.96
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 1.94
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 1.81
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 1.75
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 1.75
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 1.72
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 1.72
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 1.72
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 1.69
DAOY-Notch1/Notch2 knockout: transcriptome comparison 1.64
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 1.62
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 1.61
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 1.61
RNA sequencing of human pancreatic cancer cell lines 1.6
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 1.6
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 1.58
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 1.52
mRNA sequencing of oropharyngeal cancer cell lines 1.51
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 1.48
Noncoding regions are the main source of targetable tumor-specific antigens 1.43
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  1.43
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 1.41
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 1.41
a-synuclein accumulation in an iPSC derived model of early onset sporadic Parkinson’s Disease reveals novel drug targets 1.4
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 1.38
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 1.38
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 1.38
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 1.38
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 1.37
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 1.36
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 1.35
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 1.35
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 1.35
Identification of long noncoding RNAs in T-ALL cell lines 1.33
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 1.31
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 1.29
Transcriptional dependencies in diffuse intrinsic pontine glioma 1.29
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.26
ENCODE Cold Spring Harbor Labs Long RNA-seq 1.26
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 1.23
Fusion discovery in breast cancer cell line 1.16
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 1.15
Effect of nuclear IL-33 on gene expression 1.11
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 1.04
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 1.04
Effect of hyper-and hypoactivation of Notch signaling in IL-4-stimulate THP-1 1.01
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 1.01
Human stem cell based models of neuronal migration provide insight into neurological disease pathogenesis and potential treatment 0.88
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 0.88
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 0.86
RNA-Seq of Breast and Ovarian Cancer Cell Lines 0.85
Preclinical model of obesity and ER-positive breast cancer 0.83
Effect of BB608 on Gene Expression in HNSCC Cell Line 0.83
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 0.8
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 0.72
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 0.72
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 0.7
Transcriptomes of iPSC-derived and post-mortum Hypothalamus Neurons from obese and control donors 0.68
mRNA sequencing analysis of cultured human primary airway epithelial cells upon exposure to PMN exosomes 0.66
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 0.64
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 0.57
Gene expression analysis in response to hypoxic pathway inhibition 0.57
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 0.52
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 0.52
iPSC derived motor neuron cultures from C9ORF72 carriers 0.5
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 0.47
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 0.44
Positively selected enhancer elements endow tumor cells with metastatic competence 0.43
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 0.34
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 0.34
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 0.27
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.22
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 0.2
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 0.2
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 0.12
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 0.1
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 0.08
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 0.06
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 0.05
The control of rRNA synthesis during the directed differentiation of human embryonic stem cells precedes heterochromatin formation. 0.03
hNSCs siRNA NOVA2 0.03
A transcriptome dataset revealing the molecular features of breast cancer stem cells 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation